Skip to main content
Premium Trial:

Request an Annual Quote

Securities Firm Ups ABI s Stock, Share Price Target on Strong Fiscal Q3 Earnings

NEW YORK, April 28 (GenomeWeb News) - Piper Jaffray yesterday increased Applied Biosystems' 12-month share price target yesterday and increased the company's rating to 'Outperform.'


The securities firm now expects ABI's shares to reach $33 within 12 months. It had expected it to reach $27. The stock closed up to $28.50 yesterday.


As GenomeWeb News reported yesterday, ABI said that fiscal third-quarter sales increased 8 percent as R&D spending declined 6 percent and profits surged 121 percent.

The Scan

Could Mix It Up

The US Food and Drug Administration is considering a plan that would allow for the mixing-and-matching of SARS-CoV-2 vaccines and boosters, the New York Times says.

Closest to the Dog

New Scientist reports that extinct Japanese wolf appears to be the closest known wild relative of dogs.

Offer to Come Back

The Knoxville News Sentinel reports that the University of Tennessee is offering Anming Hu, a professor who was acquitted of charges that he hid ties to China, his position back.

PNAS Papers on Myeloid Differentiation MicroRNAs, Urinary Exosomes, Maize Domestication

In PNAS this week: role of microRNAs in myeloid differentiation, exosomes in urine, and more.